Last reviewed · How we verify

NCT04946565

The Impact of Sinopharm COVID-19 Vaccination on Male Fertility

Status unknown Last updated 7 July 2021
What this trial tests

trial testing Semen analysis in Male Infertility in 100 participants. Status unknown.

Timeline
3 July 2021
Primary endpoint
30 June 2022
30 August 2022

Quick facts

Lead sponsorCairo University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date3 July 2021
Primary completion30 June 2022
Estimated completion30 August 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 50, male only, with Male Infertility or Hypogonadism, Male. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators shall study the effect of Sinopharm vaccination on semen parameters and serum testosterone

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Semen analysis

Trials testing the same drug.

Other recruiting trials for Male Infertility

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04946565.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing